Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines
Despite significant efforts directed toward research on HIV-1 vaccines, a truly effective immunogen has not been achieved. However, the broadly neutralizing antibodies (BnAbs) 2F5 and 4E10, targeting the highly conserved membrane proximal external region (MPER) of HIV-1, are two promising tools for vaccine development. Here we engrafted the MPER into the linker domain between the trimeric core structure and the transmembrane domain of influenza A virus HA2 to investigate the potential of such chimeric viruses to elicit HIV-1 neutralizing antibodies. In the context of proliferating attenuated influenza A viruses, these HIV-1 neutralizing antibody epitopes could be continuously expressed and mimicked their native conformation to induce humoral immune responses. While MPER-specific antibodies could be detected in serum of guinea pigs vaccinated with the chimeric viruses, they exhibited only weakly neutralizing activities. These antisera from vaccinated animals neutralized viruses of clades B and BC (tier 1), but not of clades AE (tier 1) and C (tier 2). These results suggest that influenza A virus can be used as a vehicle for displaying MPER and inducing BnAbs, but it provides limited protection against HIV-1 infection. In the future development of HIV-1 vaccines by rational design, a more effective live virus vector or multiple antigens should be chosen to facilitate the process of neutralizing antibody maturation..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
Vaccine - 33(2015), 32, Seite 3859-3864 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Su, Weiheng [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antigens |
---|
doi: |
10.1016/j.vaccine.2015.06.072 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC196988875X |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC196988875X | ||
003 | DE-627 | ||
005 | 20230714175236.0 | ||
007 | tu | ||
008 | 160211s2015 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1016/j.vaccine.2015.06.072 |2 doi | |
028 | 5 | 2 | |a PQ20160211 |
035 | |a (DE-627)OLC196988875X | ||
035 | |a (DE-599)GBVOLC196988875X | ||
035 | |a (PRQ)c2092-9f40826269588f3ccec73ebd3af31e877d4f5d0cb8df288bb8a5772df60267750 | ||
035 | |a (KEY)0128923320150000033003203859elicitingneutralizingantibodiesagainstthemembranep | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
100 | 1 | |a Su, Weiheng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Despite significant efforts directed toward research on HIV-1 vaccines, a truly effective immunogen has not been achieved. However, the broadly neutralizing antibodies (BnAbs) 2F5 and 4E10, targeting the highly conserved membrane proximal external region (MPER) of HIV-1, are two promising tools for vaccine development. Here we engrafted the MPER into the linker domain between the trimeric core structure and the transmembrane domain of influenza A virus HA2 to investigate the potential of such chimeric viruses to elicit HIV-1 neutralizing antibodies. In the context of proliferating attenuated influenza A viruses, these HIV-1 neutralizing antibody epitopes could be continuously expressed and mimicked their native conformation to induce humoral immune responses. While MPER-specific antibodies could be detected in serum of guinea pigs vaccinated with the chimeric viruses, they exhibited only weakly neutralizing activities. These antisera from vaccinated animals neutralized viruses of clades B and BC (tier 1), but not of clades AE (tier 1) and C (tier 2). These results suggest that influenza A virus can be used as a vehicle for displaying MPER and inducing BnAbs, but it provides limited protection against HIV-1 infection. In the future development of HIV-1 vaccines by rational design, a more effective live virus vector or multiple antigens should be chosen to facilitate the process of neutralizing antibody maturation. | ||
540 | |a Nutzungsrecht: Copyright © 2015 Elsevier Ltd. All rights reserved. | ||
650 | 4 | |a MPER | |
650 | 4 | |a Nuclear magnetic resonance--NMR | |
650 | 4 | |a Viruses | |
650 | 4 | |a Viral infections | |
650 | 4 | |a Studies | |
650 | 4 | |a Plasmids | |
650 | 4 | |a Attenuated influenza A virus | |
650 | 4 | |a Influenza | |
650 | 4 | |a HIV-1 vaccine | |
650 | 4 | |a Antigens | |
650 | 4 | |a Proteins | |
650 | 4 | |a Peptides | |
650 | 4 | |a Vaccines | |
650 | 4 | |a Infections | |
650 | 4 | |a Immunoglobulins | |
700 | 1 | |a Kong, Wei |4 oth | |
700 | 1 | |a Zang, Yang |4 oth | |
700 | 1 | |a Nie, Jianhui |4 oth | |
700 | 1 | |a Du, Dongchuan |4 oth | |
700 | 1 | |a Jiang, Chunlai |4 oth | |
700 | 1 | |a Zhang, Yan |4 oth | |
700 | 1 | |a Li, Na |4 oth | |
700 | 1 | |a Liu, Xintao |4 oth | |
700 | 1 | |a Wang, Youchun |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Vaccine |d Amsterdam : Elsevier, 1983 |g 33(2015), 32, Seite 3859-3864 |w (DE-627)130402427 |w (DE-600)605674-X |w (DE-576)015904938 |x 0264-410X |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2015 |g number:32 |g pages:3859-3864 |
856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.vaccine.2015.06.072 |3 Volltext |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26126669 |
856 | 4 | 2 | |u http://search.proquest.com/docview/1708138938 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4219 | ||
951 | |a AR | ||
952 | |d 33 |j 2015 |e 32 |h 3859-3864 |